Product Information
NICARDIPINE 20 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $1.1201 per EA under NDC 69238269101. Its NADAC has been published 87 times since Feb 5, 2025.
FDA first approved this application on Apr 10, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238269101
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NICARDIPINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA218202FDA Approved
4/10/2024
TE Code
AB
On Market Since
10/3/2024
Pharmacological Classes
Price Statistics
The NADAC for NICARDIPINE 20 MG CAPSULE has been published 87 times since Feb 5, 2025, and over the history we have for it it has declined 63.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1201 per EA |
|---|---|
| All-time high | $3.0480 (Feb 12, 2025) |
| All-time low | $1.1201 (Sep 23, 2026) |
| 52-week high | $1.3727 |
| 52-week low | $1.1201 |
| Median price | $1.3479 |
| Average price | $1.6022 |
| Largest weekly change | -41.0% (Sep 17, 2025) |
| Weeks tracked | 87 |
| Tracking since | Feb 5, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Nicardipine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nicardipine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydropyridine Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NICARDIPINE 20 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for NICARDIPINE 20 MG CAPSULE, manufactured by Amneal Pharmaceuticals NY LLC, is $1.1201 per EA (NDC 69238269101), effective Sep 30, 2026.
How has the price of NICARDIPINE 20 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for NICARDIPINE 20 MG CAPSULE has declined 63.3%. It has been tracked across 87 weekly CMS publications since Feb 5, 2025.
What are the highest and lowest recorded NADAC prices for NICARDIPINE 20 MG CAPSULE?
Since Feb 5, 2025, the NADAC for NICARDIPINE 20 MG CAPSULE has ranged from a low of $1.1201 (Sep 23, 2026) to a high of $3.0480 (Feb 12, 2025), with a median of $1.3479 per EA.
Are there cheaper alternatives to NICARDIPINE 20 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of NICARDIPINE 20 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NICARDIPINE 20 MG CAPSULE?
NICARDIPINE 20 MG CAPSULE (NDC 69238269101) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.